Withania somnifera Water Extract as a Potential Candidate for Differentiation Based Therapy of Human Neuroblastomas

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kataria, Hardeep ^a   Wadhwa, Renu ^b   Kaul, Sunil C ^b   Kaur, Gurcharan ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 70; NERVE CELL ADHESION MOLECULE; NEUROFILAMENT 200 PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN BCL XL; PROTEIN KINASE B; TUMOR MARKER; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL TRANSPORT; CONTROLLED STUDY; DIFFERENTIATION BASED THERAPY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROFILAMENT; NONHUMAN; PROTEIN EXPRESSION; SIALYLATION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION;

ANNEXIN A5; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FLUORESCEIN-5-ISOTHIOCYANATE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NEURAL CELL ADHESION MOLECULES; NEUROBLASTOMA; PHYTOTHERAPY; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WATER; WITHANIA;

EID: 84873142408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055316     Document Type: Article

References (80)

1. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E, (2006) Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42: 2081-2091.
2. Matthay KK, Yanik G, Messina J, Quach A, Huberty J, et al. (2007) Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol 25: 1054-1060.
3. Armstrong JL, Ruiz M, Boddy AV, Redfern CP, Pearson AD, et al. (2005) Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells. Br J Cancer 92: 696-704.
4. Armstrong JL, Taylor GA, Thomas HD, Boddy AV, Redfern CP, et al. (2007) Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo. Br J Cancer 96: 1675-1683.
5. Njar VC, Gediya L, Purushottamachar P, Chopra P, Belosay A, et al. (2006) Retinoids in clinical use. Med Chem 2: 431-438.
6. Gupta GL, Rana AC, (2007) Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in rats. Indian J Physiol Pharmacol 51: 345-353.
7. Matsuda H, Murakami T, Kishi A, Yoshikawa M, (2001) Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem 9: 1499-1507.
8. Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, et al. (2008) Withanolides from Withania somnifera roots. Phytochemistry 69: 1000-1004.
9. Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, (2012) 1,4-Dioxane and ergosterol derivatives from Withania somnifera roots. J Asian Nat Prod Res 14: 39-45.
10. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, et al. (2007) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12: 2115-2133.
11. Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, Dewitt DL, et al. (2009) Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res 23: 987-992.
12. Jayaprakasam B, Padmanabhan K, Nair MG, (2010) Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Phytother Res 24: 859-863.
13. Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ, (2010) In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and beta-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res 24: 1567-1574.
14. Kataria H, Wadhwa R, Kaul SC, Kaur G, (2012) Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity. PLoS One 7(5): e37080 doi:10.1371/journal.pone.0037080.
15. Katayama M, Mizuta I, Sakoyama Y, Kohyama-Koganeya A, Akagawa K, et al. (1997) Differential expression of neuroD in primary cultures of cerebral cortical neurons. Exp Cell Res 236: 412-417.
16. Elder GA, Friedrich VL Jr, Kang C, Bosco P, Gourov A, et al. (1998) Requirement of heavy neurofilament subunit in the development of axons with large calibers. J Cell Biol 143: 195-205.
17. Heikkila JJ, (1993) Heat shock gene expression and development. II. An overview of mammalian and avian developmental systems. Dev Genet 14: 87-91.
18. Loones MT, Chang Y, Morange M, (2000) The distribution of heat shock proteins in the nervous system of the unstressed mouse embryo suggests a role in neuronal and non-neuronal differentiation. Cell Stress Chaperones 5: 291-305.
19. Chiasserini D, Tozzi A, de Iure A, Tantucci M, Susta F, et al. (2011) Mortalin Inhibition in Experimental Parkinson's Disease. Movement Disorders 26: 1639-1647.
20. Qu MY, Zhou Z, Xu SC, Chen CH, Yu ZP, et al. (2011) Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells. Brain Research 1368: 336-345.
21. Shih YY, Lee H, Nakagawara A, Juan HF, Jeng YM, et al. (2011) Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. PLoS One 6: e26236.
22. Perl AK, Dahl U, Wilgenbus P, Cremer H, Semb H, et al. (1999) Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. Nat Med 5: 286-291.
23. Cavallaro U, Niedermeyer J, Fuxa M, Christofori G, (2001) N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat Cell Biol 3: 650-657.
24. Muhlenhoff M, Eckhardt M, Gerardy-Schahn R, (1998) Polysialic acid: three-dimensional structure, biosynthesis and function. Curr Opin Struct Biol 8: 558-564.
25. Rutishauser U, Landmesser L, (1996) Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci 19: 422-427.
26. Yang L, Dan HC, Sun M, Liu Q, Sun XM, et al. (2004) Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64: 4394-4399.
27. Shim JW, Koh HC, Chang MY, Roh E, Choi CY, et al. (2004) Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J Neurosci 24: 843-852.
28. Georgopoulou N, Hurel C, Politis PK, Gaitanou M, Matsas R, et al. (2006) BM88 is a dual function molecule inducing cell cycle exit and neuronal differentiation of neuroblastoma cells via cyclin D1 down-regulation and retinoblastoma protein hypophosphorylation. J Biol Chem 281: 33606-33620.
29. Kataria H, Shah N, Kaul SC, Wadhwa R, Kaur G (2011) Water Extract of Ashwagandha Leaves Limits Proliferation and Migration, and Induces Differentiation in Glioma Cells. Evid Based Complement Alternat Med 2011, Article ID 267614. doi:10.1093/ecam/nep188.
30. Sidell N, Altman A, Haussler MR, Seeger RC, (1983) Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 148: 21-30.
31. Guan K, Chang H, Rolletschek A, Wobus AM, (2001) Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 305: 171-176.
32. Kuboyama T, Tohda C, Komatsu K, (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol. 144: 961-971.
33. Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, et al. (2002) Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport 13: 1715-1720.
34. Black MM, Chestnut MH, Pleasure IT, Keen JH, (1991) Stable clathrin: uncoating protein (hsc70) complexes in intact neurons and their axonal transport. J Neurosci 11: 1163-1172.
35. Yang J, Oza J, Bridges K, Chen KY, Liu AY, (2008) Neural differentiation and the attenuated heat shock response. Brain Res 1203: 39-50.
36. Westerheide SD, Bosman JD, Mbadugha BN, Kawahara TL, Matsumoto G, et al. (2004) Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279: 56053-56060.
37. Wadhwa R, Mitsui Y, Ide T, Kaul S, (1995) The antiproliferative aspects of mortalin (review). Int J Oncol 7: 69-74.
38. Wadhwa R, Taira K, Kaul SC, (2002) An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones 7: 309-316.
39. Hsu WM, Lee H, Juan HF, Shih YY, Wang BJ, et al. (2008) Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Clin Cancer Res 14: 6237-6245.
40. Shah N, Kataria H, Kaul SC, Ishii T, Kaur G, et al. (2009) Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci 100: 1740-1747.
41. Donnellan R, Chetty R, (1998) Cyclin D1 and human neoplasia. Mol Pathol 51: 1-7.
42. Molenaar JJ, Ebus ME, Koster J, Santo E, Geerts D, et al. (2010) Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene 29: 2739-2745.
43. Sallinen SL, Sallinen PK, Kononen JT, Syrjakoski KM, Nupponen NN, et al. (1999) Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis. J Pathol 188: 289-293.
44. Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, et al. (2009) Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A 106: 12968-12973.
45. Cesi V, Tanno B, Vitali R, Mancini C, Giuffrida ML, et al. (2002) Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation. Cell Death Differ 9: 1232-1239.
46. McClellan KA, Slack RS, (2006) Novel functions for cell cycle genes in nervous system development. Cell Cycle 5: 1506-1513.
47. Sumrejkanchanakij P, Eto K, Ikeda MA, (2006) Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells. Biochem Biophys Res Commun 340: 302-308.
48. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA, (2003) Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 22: 8723-8730.
49. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, et al. (1999) The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20: 501-534.
50. Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, et al. (2008) Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68: 2599-2609.
51. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G, et al. (1995) Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55: 2576-2582.
52. Sukumari-Ramesh S, Bentley JN, Laird MD, Singh N, Vender JR, et al. (2011) Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells. Int J Dev Neurosci 29: 701-710.
53. Singh AP, Lange TS, Kim KK, Brard L, Horan T, et al. (2012) Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cells. Int J Oncol 40: 99-108.
54. Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, et al. (2008) Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. Cancer Lett 262: 37-47.
55. Evangelopoulos ME, Weis J, Kruttgen A, (2005) Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 24: 3309-3318.
56. Evangelopoulos ME, Weis J, Kruttgen A, (2009) Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR. J Neurosci Res 87: 2138-2144.
57. Takahashi K, Piao S, Yamatani H, Du B, Yin L, et al. (2011) Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells. Mol Cell Neurosci 48: 217-224.
58. Perez-Tenorio G, Stal O, (2002) Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer 86: 540-545.
59. Huang EJ, Reichardt LF, (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72: 609-642.
60. Reichardt LF, Bixby JL, Hall DE, Ignatius MJ, Neugebauer KM, et al. (1989) Integrins and cell adhesion molecules: neuronal receptors that regulate axon growth on extracellular matrices and cell surfaces. Dev Neurosci 11: 332-347.
61. Martini R, Xin Y, Schachner M, (1994) Restricted localization of L1 and N-CAM at sites of contact between Schwann cells and neurites in culture. Glia 10: 70-74.
62. Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, et al. (2001) Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule. Surgery 130: 834-843.
63. Horstkorte R, Muhlenhoff M, Reutter W, Nohring S, Zimmermann-Kordmann M, et al. (2004) Selective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids. Exp Cell Res 298: 268-274.
64. Kiss JZ, Rougon G, (1997) Cell biology of polysialic acid. Curr Opin Neurobiol 7: 640-646.
65. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, et al. (2000) Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. Cancer Res 60: 3072-3080.
66. Gallagher HC, Odumeru OA, Regan CM, (2000) Regulation of neural cell adhesion molecule polysialylation state by cell-cell contact and protein kinase C delta. J Neurosci Res 61: 636-645.
67. Hildebrandt H, Becker C, Gluer S, Rosner H, Gerardy-Schahn R, et al. (1998) Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. Cancer Res 58: 779-784.
68. Fukuda M, (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56: 2237-2244.
69. Mahal LK, Charter NW, Angata K, Fukuda M, Koshland DE Jr, et al. (2001) A small-molecule modulator of poly-alpha 2,8-sialic acid expression on cultured neurons and tumor cells. Science 294: 380-381.
70. Miyazaki T, Angata K, Seeberger PH, Hindsgaul O, Fukuda M, (2008) CMP substitutions preferentially inhibit polysialic acid synthesis. Glycobiology 18: 187-194.
71. Yoshida Y, Kurosawa N, Kanematsu T, Kojima N, Tsuji S, (1996) Genomic structure and promoter activity of the mouse polysialic acid synthase gene (mST8Sia II). Brain-specific expression from a TATA-less GC-rich sequence. J Biol Chem 271: 30167-30173.
72. Takashima S, Yoshida Y, Kanematsu T, Kojima N, Tsuji S, (1998) Genomic structure and promoter activity of the mouse polysialic acid synthase (mST8Sia IV/PST) gene. J Biol Chem 273: 7675-7683.
73. Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, et al. (2002) Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 22: 9868-9876.
74. Bruses JL, Rutishauser U, (1998) Regulation of neural cell adhesion molecule polysialylation: evidence for nontranscriptional control and sensitivity to an intracellular pool of calcium. J Cell Biol 140: 1177-1186.
75. Ray SD, Fariss MW, (1994) Role of cellular energy status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity. Arch Biochem Biophys 311: 180-190.
76. Chambers AF, Matrisian LM, (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270.
77. Deb S, Gottschall PE, (1996) Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 66: 1641-1647.
78. Noujaim D, van Golen CM, van Golen KL, Grauman A, Feldman EL, (2002) N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 21: 4549-4557.
79. Deryugina EI, Quigley JP, (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34.
80. Arato-Ohshima T, Sawa H, (1999) Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer 83: 387-392.